Alessandro Costa

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 14

Top Topics

Combination Therapy

End Stage Renal Disease

Chronic Myeloid Leukemia

Ejection Fraction

Top Venues

Journal of clinical medicine

British journal of haematology

Expert opinion on drug safety

European journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Alessandro Laganà, Emilia Scalzulli, Maria Laura Bisegna, Ida Carmosino, Claudia Ielo, Alessandro Costa, Lorenzo Torrieri, Matteo Totaro, Maurizio Martelli, Massimo Breccia
Treatment free remission (TFR) after second-generation tyrosine kinase inhibitors (2G-TKIs) treatment in chronic myeloid leukemia (CML): from feasibility to safety. Expert opinion on drug safety (2024)
Alessandro Costa, Elisabetta Abruzzese, Roberto Latagliata, Olga Mulas, Ida Carmosino, Emilia Scalzulli, Maria Laura Bisegna, Claudia Ielo, Maurizio Martelli, Giovanni Caocci, Massimo Breccia
Safety and Efficacy of TKIs in very Elderly Patients (≥75 Years) with Chronic Myeloid Leukemia. Journal of clinical medicine 13 (1) (2024)
Alessandro Laganà, Emilia Scalzulli, Maria Laura Bisegna, Ida Carmosino, Claudia Ielo, Alessandro Costa, Lorenzo Torrieri, Matteo Totaro, Maurizio Martelli, Massimo Breccia
Treatment free remission (TFR) after second-generation tyrosine kinase inhibitors (2G-TKIs) treatment in chronic myeloid leukemia (CML): from feasibility to safety. Expert opinion on drug safety 23 (8) (2024)
Alessandro Laganà, Mauro Passucci, Sara Pepe, Emilia Scalzulli, Ida Carmosino, Alessandro Costa, Maria Laura Bisegna, Claudia Ielo, Maurizio Martelli, Massimo Breccia
Neutrophil to lymphocyte ratio in myelofibrosis patients treated with ruxolitinib may predict prognosis and rate of discontinuation. European journal of haematology (2024)
Alessandro Laganà, Emilia Scalzulli, Maria Laura Bisegna, Ida Carmosino, Claudia Ielo, Alessandro Costa, Lorenzo Torrieri, Matteo Totaro, Maurizio Martelli, Massimo Breccia
Treatment free remission (TFR) after second-generation tyrosine kinase inhibitors (2G-TKIs) treatment in chronic myeloid leukemia (CML): from feasibility to safety. Expert opinion on drug safety (2024)
Alessandro Laganà, Mauro Passucci, Sara Pepe, Emilia Scalzulli, Ida Carmosino, Alessandro Costa, Maria Laura Bisegna, Claudia Ielo, Maurizio Martelli, Massimo Breccia
Neutrophil to lymphocyte ratio in myelofibrosis patients treated with ruxolitinib may predict prognosis and rate of discontinuation. European journal of haematology 112 (6) (2024)
Alessandro Costa, Elisabetta Abruzzese, Roberto Latagliata, Olga Mulas, Ida Carmosino, Emilia Scalzulli, Maria Laura Bisegna, Claudia Ielo, Maurizio Martelli, Giovanni Caocci, Massimo Breccia
Safety and Efficacy of TKIs in very Elderly Patients (≥75 Years) with Chronic Myeloid Leukemia. Journal of clinical medicine 13 (1) (2024)
Alessandro Costa, Massimo Breccia
How to improve treatment-free remission eligibility in chronic myeloid leukaemia? British journal of haematology 204 (2) (2023)
Alessandro Costa, Massimo Breccia
How to improve treatment-free remission eligibility in chronic myeloid leukaemia? British journal of haematology (2023)
Alessandro Costa, Massimo Breccia
How to improve treatment-free remission eligibility in chronic myeloid leukaemia? British journal of haematology 204 (2) (2023)
Alessandro Costa, Massimo Breccia
How to improve treatment-free remission eligibility in chronic myeloid leukaemia? British journal of haematology 204 (2) (2023)
Giovanni Caocci, Olga Mulas, Susanna Barella, Valeria Orecchia, Brunella Mola, Alessandro Costa, Fabio Efficace, Giorgio La Nasa
Long-Term Health-Related Quality of Life and Clinical Outcomes in Patients with β-Thalassemia after Splenectomy. Journal of clinical medicine 12 (7) (2023)
Alessandro Costa, Ida Carmosino, Emilia Scalzulli, Clara Minotti, Maria Stefania De Propris, Chiara Masucci, Mauro Passucci, Maria Laura Bisegna, Claudia Ielo, Sara Pepe, Daniela Diverio, Maurizio Martelli, Massimo Breccia
Early death risk score in acute promyelocytic leukemia: A retrospective analysis from a monocentric cohort. European journal of haematology (2023)
Olga Mulas, Fabio Efficace, Maria Grazia Orofino, Antonio Piroddi, Eugenia Piras, Adriana Vacca, Susanna Barella, Alessandro Costa, Johannes M Giesinger, Giorgio La Nasa, Giovanni Caocci
Health-Related Quality-of-Life Profile of Pediatric Patients with β Thalassemia after Hematopoietic Stem Cell Transplantation. Journal of clinical medicine 12 (18) (2023)